CEPH Message Board - Msg: 909075

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bysfbay who wrote (58)	3/1/1997 3:37:00 PM
From: harkenman	of 998

Those two are the only ones withing CEPH with brains. Its a job you know which pays well. Check out CEPH lastest SEC filing which sounds depressing but it is the truth. They have no track record of getting approvals. Check it out yourself. Even the J&J and Mercks have a hard time getting approvals. The WSJ news published recently about the non-decision on FDA requiring a third Phase III study didn't help the stock. A lot of people are banking on a drug used for an orphan disease (1 in 100,000) stats which is very low and failed a european efficacy study. A lot of people are buying this stock based on succesfull manipulation of the press. Standard and Poor rates it AVOID the last time I checked and Value Line rates it only for the speculative investors. First Call puts em still at a loss for '97. Wait until summer to see it tank big time! With no news a see a price of 18, with negative news a price of less than 9. I shorted at 26 in January 1997 and plan to cover at 18. I shorted in November 1996 at 22 and covered late December at 18 before it started to go up. I have been tracking this stock for some time (1.5 years) and have seen how the company uses the press quite effectively.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next